U.S. Markets open in 1 hr, 23 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,450.95 | 132.79 | 1.29% |
| NASDAQ | 2,176.01 | 29.97 | 1.40% |
| S&P 500 | 1,106.24 | 14.86 | 1.36% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Date | Time(ET) | Upcoming Events | Set Alert |
|---|---|---|---|
| 03/01/2010 * | 18:00 | Q4 2009 Allos Therapeutics, Inc. Earnings Release |  |
| Date | Previous Event | Listen | Transcript/Brief |
|---|---|---|---|
| 11/17/2009 | Allos Therapeutics, Inc. at Lazard Capital Healthcare Conference |  |
— |
| 11/03/2009 | Q3 2009 Allos Therapeutics, Inc. Earnings Conference Call | |
Download($) |
| 11/03/2009 | Q3 2009 Allos Therapeutics, Inc. Earnings Release | — | — |
| 09/25/2009 | Allos Therapeutics, Inc. Conference Call to Discuss FOLOTYN: First and Only FDA-Approved Therapy for Relapsed or Refractory PTCL | |
Download($) |
| 09/03/2009 | Allos Therapeutics, Inc. to Hold Post Advisory Committee Conference Call | |
Download($) |
| 08/04/2009 | Q2 2009 Allos Therapeutics, Inc. Earnings Conference Call | |
Download($) |
| 08/04/2009 | Q2 2009 Allos Therapeutics, Inc. Earnings Release | — | — |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts